Search results
Results from the WOW.Com Content Network
Human cytomegalovirus group Cytomegalovirus ( CMV ) (from cyto- 'cell' via Greek κύτος kútos - 'container' + μέγας mégas 'big, megalo-' + - virus via Latin vīrus 'poison') is a genus of viruses in the order Herpesvirales , in the family Herpesviridae , [ 3 ] in the subfamily Betaherpesvirinae .
Human cytomegalovirus (HCMV), also called human herpesvirus 5 (HHV-5), is a species of virus in the genus Cytomegalovirus, which in turn is a member of the viral family known as Herpesviridae or herpesviruses. It is also commonly called CMV. [3]
Human cytomegalovirus (HCMV, HHV-5) "seems to have a large impact on immune parameters in later life and may contribute to increased morbidity and eventual mortality." [ 5 ] Human herpesvirus 6A (HHV-6A) has been described as more neurovirulent, [ 6 ] and as such is more frequently found in patients with neuroinflammatory diseases such as ...
A new study found a link between cytomegalovirus (CMV) and Alzheimer's disease. Here's what a neurologist wants you to know, plus how to protect yourself.
Cytomegalic inclusion body disease (CIBD) also known as cytomegalic inclusion disease (CID) is a series of signs and symptoms caused by cytomegalovirus infection, toxoplasmosis or other rare infections such as herpes or rubella viruses. It can produce massive calcification of the central nervous system, and often the kidneys. [1]
Congenital cytomegalovirus (cCMV) is cytomegalovirus (CMV) infection in a newborn baby. [1] Most have no symptoms. [1] Some affected babies are small. [1] Other signs and symptoms include a rash, jaundice, hepatomegaly, retinitis, and seizures. [1] [2] It may lead to loss of hearing or vision, developmental disability, or a small head. [1]
Human herpesvirus 7 (HHV-7) is one of nine known members of the Herpesviridae family that infects humans. HHV-7 is a member of Betaherpesvirinae , a subfamily of the Herpesviridae that also includes HHV-6 and Cytomegalovirus (HHV-5 or HCMV).
A Cytomegalovirus vaccine is a vaccine to prevent cytomegalovirus (CMV) infection or curb virus re-activation (symptomatic flare-ups) in persons already infected. Challenges in developing a vaccine include adeptness of CMV in evading the immune system and limited animal models. [ 1 ]